Sign in

CIK 0001731348 · Large accelerated filer

Tilray Brands, Inc.

Sign in to watch
Ticker
TLRY
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
FY end
May 31
Entity type
operating
EIN
824310622
Phone
519.322.8800
Business address
445 PARK AVENUE, NEW YORK, NY, 10022
Former names
Tilray, Inc.
  1. 4 Option exercise Chief Strategy Officer acquired 25,510 shares (option exercise)
  2. 4 Option exercise Director acquired 70,621 shares (option exercise)
  3. 4 Option exercise Director acquired 70,621 shares (option exercise)
  4. 4 Option exercise Director acquired 70,621 shares (option exercise)
  5. 4 Option exercise Director acquired 70,621 shares (option exercise)
  6. 4 Option exercise Director acquired 70,621 shares (option exercise)
  7. 4 Option exercise Director acquired 70,621 shares (option exercise)
  8. 4 Option exercise Director acquired 3,858 shares (option exercise)
  9. 4 Option exercise Director acquired 3,858 shares (option exercise)
  10. 4 Option exercise Director acquired 3,858 shares (option exercise)
  11. 4 Option exercise Director acquired 3,858 shares (option exercise)
  12. 4 Option exercise Director acquired 3,858 shares (option exercise)
  13. 4 Option exercise Director acquired 3,858 shares (option exercise)
  14. 4 Option exercise President and CEO acquired 731,193 shares (option exercise)
  15. 4 Option exercise Global General Counsel acquired 121,268 shares (option exercise)
  16. 4 Option exercise Chief Strategy Officer acquired 139,806 shares (option exercise)
  17. 4 Option exercise Chief Financial Officer acquired 108,971 shares (option exercise)
  18. 4 Open-market sale Director sold 350,000 shares at $3.78 ($1,322,755)
  19. 4 Open-market sale Director sold 350,000 shares at $2.91 ($1,018,395)
  20. 4 Open-market sale Director sold 350,000 shares at $3.22 ($1,128,015)

Page 5 of 17 · 334 filings